Rigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States. The company offers TAVALISSE, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with...
21 insider purchases on record · latest filing 2022-06-13.
Insiders have also filed 56 sale transactions at RIGL.